Literature DB >> 18614153

[Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?].

M François1, N Lévy-Bohbot, J Caron, V Durlach.   

Abstract

Hypomagnesemia is a rare cause of hypoparathyroidism that can have a very serious clinical presentation. We report the case of a 62-year-old woman hospitalized for exploration of acute tetraparesis with vomiting and swallowing disorders associated with a severe hypocalcemia. Biological explorations revealed hypoparathyroidism (PTH=16ng/L) related to low plasma and erythrocyte magnesium (0.32 and 1.32mmol/L, respectively) as well as hypocalciuria and hypomagnesuria linked to gastrointestinal malabsorption. Etiologic investigations led to the discovery of Giardiasis lamblia on duodenal biopsies and a long-term treatment with proton pump inhibitors (PPI) (omeprazole followed by esomeprazole), both being recently described as causal factors of hypomagnesemic hypoparathyroidism. After treatment of the parasite (by metronidazole) and discontinuation of the PPI, both calcium and magnesium levels returned to normal. Selective malabsorption has been previously reported in patients with giardiasis. The specific mechanism of PPI participation in the genesis of hypomagnesemia remains a subject of debate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614153     DOI: 10.1016/j.ando.2008.03.003

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  10 in total

1.  Severe hypomagnesaemia due to lansoprazole.

Authors:  Chit Hmu; Probal Moulik; Andrew Macleod
Journal:  BMJ Case Rep       Date:  2009-12-17

Review 2.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

Review 3.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

Review 4.  A review of drug-induced hypocalcemia.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  J Bone Miner Metab       Date:  2009       Impact factor: 2.626

Review 5.  Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Curr Gastroenterol Rep       Date:  2010-12

6.  Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors.

Authors:  Fernanda A Goncalves; Jessica Santos de Jesus; Lilian Cordeiro; Maria Clara T Piraciaba; Luiza K R P de Araujo; Carolina Steller Wagner Martins; Maria Aparecida Dalboni; Benedito J Pereira; Bruno C Silva; Rosa Maria A Moysés; Hugo Abensur; Rosilene M Elias
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

7.  Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Authors:  Ioannis Koulouridis; Mansour Alfayez; Hocine Tighiouart; Nicolaos E Madias; David M Kent; Jessica K Paulus; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2013-05-10       Impact factor: 8.860

Review 8.  Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.

Authors:  Simone Janett; Pietro Camozzi; Gabriëlla G A M Peeters; Sebastiano A G Lava; Giacomo D Simonetti; Barbara Goeggel Simonetti; Mario G Bianchetti; Gregorio P Milani
Journal:  Gastroenterol Res Pract       Date:  2015-05-04       Impact factor: 2.260

9.  The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia.

Authors:  Yong Ting Tai; Chin Vong Tong
Journal:  J ASEAN Fed Endocr Soc       Date:  2020-04-20

10.  Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature.

Authors:  Aileen K Wang; Shweta Sharma; Paul Kim; Karen Mrejen-Shakin
Journal:  Indian J Crit Care Med       Date:  2014-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.